Nova Patents
ATE298002T1

Hereditary hemochromatosis gene

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 4 April 2017, 9.5 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

54 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims4

Priority claims
DocumentOfficeKindDate
63091296United States of AmericaA
63267396United States of AmericaA
65226596United States of AmericaA
9706254United States of AmericaW

Members54

Family members, oldest first
DocumentOfficeKind
CA2253240A1CanadaA1
WO9738137A1World Intellectual Property Organization (WIPO)A1
AU2670197AAustraliaA
US5712098AUnited States of AmericaA
CA2268771A1CanadaA1
WO9814466A1World Intellectual Property Organization (WIPO)A1
AU4803997AAustraliaA
ZA978804BSouth AfricaB
US5872237AUnited States of AmericaA
EP0954602A1European Patent Office (EPO)A1
EP0960114A1European Patent Office (EPO)A1
US6025130AUnited States of AmericaA
US6140305AUnited States of AmericaA
US6228594B1United States of AmericaB1
AU733459B2AustraliaB2
JP2001525663AJapanA
DE954602T1GermanyT1
DE960114T1GermanyT1
EP0954602A4European Patent Office (EPO)A4
US2003100747A1United States of AmericaA1
US2003148972A1United States of AmericaA1
EP0960114A4European Patent Office (EPO)A4
US6849399B1United States of AmericaB1
US2005090430A1United States of AmericaA1
EP0954602B1European Patent Office (EPO)B1
AT298002TAustriaT
ATE298002T1This recordAustriaT1
DE69733572D1GermanyD1
EP1591537A2European Patent Office (EPO)A2
US2005266481A1United States of AmericaA1
US7026116B1United States of AmericaB1
DE69733572T2GermanyT2
US7052845B2United States of AmericaB2
US7067255B2United States of AmericaB2
US7078513B1United States of AmericaB1
US2006177854A1United States of AmericaA1
EP1591537A3European Patent Office (EPO)A3
EP0960114B1European Patent Office (EPO)B1
DE69738157D1GermanyD1
JP4017672B2JapanB2
EP1914319A2European Patent Office (EPO)A2
DE69738157T2GermanyT2
US7374765B2United States of AmericaB2
CA2268771CCanadaC
US7579169B2United States of AmericaB2
US7595385B2United States of AmericaB2
EP1914319A3European Patent Office (EPO)A3
US2010204051A1United States of AmericaA1
CA2253240CCanadaC
US7998680B2United States of AmericaB2
US2011269122A1United States of AmericaA1
US8257927B2United States of AmericaB2
EP1914319B1European Patent Office (EPO)B1
EP1591537B1European Patent Office (EPO)B1